Loading company
Loading
Open Financials SINOVAC BIOTECH LTD (SVA) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $386 million | $361.4 million | +6.8% | 20-F 2026-06-05 · proof |
| Gross profit | $262 million | $220.7 million | +18.7% | 20-F 2026-06-05 · proof |
| Operating income | -$490.1 million | -$505.5 million | 20-F 2026-06-05 · proof | |
| Net income | -$198.8 million | $40.7 million | -589.1% | 20-F 2026-06-05 · proof |
| Cash from operating activities | -$512.2 million | -$56.9 million | 20-F 2026-06-05 · proof | |
| Free cash flow | -$561.1 million | -$152.9 million | 20-F 2026-06-05 · proof | |
| Total assets | $8.5 billion | $12.3 billion | -30.8% | 20-F 2026-06-05 · proof |
| Total liabilities | $2.1 billion | $2 billion | +5% | 20-F 2026-06-05 · proof |
| Cash and cash equivalents | $488.2 million | $335.3 million | +45.6% | 20-F 2026-06-05 · proof |
- What was SINOVAC BIOTECH LTD (SVA)'s revenue in fiscal 2025?
- SINOVAC BIOTECH LTD (SVA) reported revenue of $386 million for fiscal 2025 (the year ended Dec 31, 2025), against $361.4 million the year before (+6.8%). Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
- What was SINOVAC BIOTECH LTD (SVA)'s gross profit in fiscal 2025?
- SINOVAC BIOTECH LTD (SVA) reported gross profit of $262 million for fiscal 2025 (the year ended Dec 31, 2025), against $220.7 million the year before (+18.7%). Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
- What was SINOVAC BIOTECH LTD (SVA)'s operating income in fiscal 2025?
- SINOVAC BIOTECH LTD (SVA) reported operating income of -$490.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$505.5 million the year before. Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
- What was SINOVAC BIOTECH LTD (SVA)'s net income in fiscal 2025?
- SINOVAC BIOTECH LTD (SVA) reported net income of -$198.8 million for fiscal 2025 (the year ended Dec 31, 2025), against $40.7 million the year before (-589.1%). Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
- What was SINOVAC BIOTECH LTD (SVA)'s cash from operating activities in fiscal 2025?
- SINOVAC BIOTECH LTD (SVA) reported cash from operating activities of -$512.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$56.9 million the year before. Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
- What was SINOVAC BIOTECH LTD (SVA)'s free cash flow in fiscal 2025?
- SINOVAC BIOTECH LTD (SVA) reported free cash flow of -$561.1 million for fiscal 2025 (the year ended Dec 31, 2025), against -$152.9 million the year before. Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
- What are SINOVAC BIOTECH LTD (SVA)'s total assets?
- As of Dec 31, 2025, SINOVAC BIOTECH LTD (SVA) reported total assets of $8.5 billion, against $12.3 billion a year earlier (-30.8%). Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
- What are SINOVAC BIOTECH LTD (SVA)'s total liabilities?
- As of Dec 31, 2025, SINOVAC BIOTECH LTD (SVA) reported total liabilities of $2.1 billion, against $2 billion a year earlier (+5%). Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
- What are SINOVAC BIOTECH LTD (SVA)'s cash and cash equivalents?
- As of Dec 31, 2025, SINOVAC BIOTECH LTD (SVA) reported cash and cash equivalents of $488.2 million, against $335.3 million a year earlier (+45.6%). Source: the 20-F filed with the SEC on Jun 5, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:SVA&period_type=annual&limit=5"Information only, not investment advice.